Windtree Therapeutics
(OTC) WINT
Windtree Therapeutics Financials at a Glance
Market Cap
$498,900
Revenue (TTM)
$90.00K
Net Income (TTM)
$40.00M
EPS (TTM)
$-8.51
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$0.01
Volume
1,969,823
Open
$0.01
Price
$0.01
Volume
1,969,823
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.02
52-Week Range
$0.01 - $2.17
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$0.01
Volume
1,969,823
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.02
52-Week Range
$0.01 - $2.17
WINT News
WINT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Windtree Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Jed Andrew Latkin, MBA
Website
www.windtreetx.comHeadquarters
Warrington, PA 18976-3622, US
WINT Financials
Key Financial Metrics (TTM)
Gross Margin
12%
Operating Margin
-372%
Net Income Margin
-444%
Return on Equity
-170%
Return on Capital
6%
Return on Assets
-3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-1.00%
Stock Overview
Market Cap
$498.90K
Shares Outstanding
33.71M
Volume
1.97M
Short Interest
0.00%
Avg. Volume
408.43K
Financials (TTM)
Gross Profit
$84.00K
Operating Income
$25.02M
EBITDA
$1.47M
Operating Cash Flow
$15.40M
Capital Expenditure
$12.00K
Free Cash Flow
$15.41M
Cash & ST Invst.
$1.78M
Total Debt
$1.82M
Windtree Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$498.90K
N/A
Market Cap/Employee
$35.64K
N/A
Employees
14
N/A
Net Income
$28.09M
-921.6%
EBITDA
$30.83M
-996.7%
Quarterly Fundamentals
Net Cash
$12.72M
-4533.4%
Accounts Receivable
$5.80M
N/A
Inventory
$0.00
N/A
Long Term Debt
$240.00K
-69.4%
Short Term Debt
$12.69M
+932.4%
Return on Assets
-2.50%
N/A
Return on Invested Capital
5.66%
N/A
Free Cash Flow
$6.37M
+1.1%
Operating Cash Flow
$6.37M
+1.1%